Gene · 9656
Papers2,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting DNA Repair, Cell Cycle, and Tumor Microenvironment in B Cell Lymphoma. | Cells | 2020 | 33066395 | PubTator, text mining | PubMed |
| The NS1 protein of the parvovirus MVM Aids in the localization of the viral genome to cellular sites of DNA damage. | PLoS Pathog | 2020 | 33064772 | PubTator, text mining | PubMed |
| Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy - potential clinical relevance. | Cell Oncol (Dordr) | 2020 | 33052585 | PubTator, text mining | PubMed |
| Inactivation of ribosomal protein S27-like impairs DNA interstrand cross-link repair by destabilization of FANCD2 and FANCI. | Cell Death Dis | 2020 | 33051438 | PubTator, text mining | PubMed |
| Sarcoma treatment in the era of molecular medicine. | EMBO Mol Med | 2020 | 33047515 | PubTator, text mining | PubMed |
| Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma. | Nat Med | 2020 | 33046869 | PubTator, text mining | PubMed |
| Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma? | Cancers (Basel) | 2020 | 33036368 | PubTator, text mining | PubMed |
| Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes. | JAMA Netw Open | 2020 | 33017027 | PubTator, text mining | PubMed |
| Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays. | Biol Proced Online | 2020 | 33013205 | PubTator, text mining | PubMed |
| CK2 kinase-mediated PHF8 phosphorylation controls TopBP1 stability to regulate DNA replication. | Nucleic Acids Res | 2020 | 33010150 | PubTator, text mining | PubMed |
| Deciphering heterogeneity of septic shock patients using immune functional assays: a proof of concept study. | Sci Rep | 2020 | 32999313 | PubTator, text mining | PubMed |
| Nanoscale insight into chromatin remodeling and DNA repair complex in HeLa cells after ionizing radiation. | DNA Repair (Amst) | 2020 | 32998084 | PubTator, text mining | PubMed |
| Under-Replicated DNA: The Byproduct of Large Genomes? | Cancers (Basel) | 2020 | 32992928 | PubTator, text mining | PubMed |
| Recent advancements in PARP inhibitors-based targeted cancer therapy. | Precis Clin Med | 2020 | 32983586 | PubTator, text mining | PubMed |
| De novo transcriptome analysis and gene expression profiling of fish scales isolated from Carassius auratus during space flight: Impact of melatonin on gene expression in response to space radiation. | Mol Med Rep | 2020 | 32945420 | PubTator, text mining | PubMed |
| Genomic instability and mitochondrial homeostasis in cancer: does chromatin have a say? | Mol Cell Oncol | 2020 | 32944631 | PubTator, text mining | PubMed |
| Matrix metalloproteinase 9 (MMP9) limits reactive oxygen species (ROS) accumulation and DNA damage in colitis-associated cancer. | Cell Death Dis | 2020 | 32943603 | PubTator, text mining | PubMed |
| Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target Approach. | Int J Mol Sci | 2020 | 32932697 | PubTator, text mining | PubMed |
| A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis. | Theranostics | 2020 | 32929379 | PubTator, text mining | PubMed |
| Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers. | Theranostics | 2020 | 32929364 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9656/papers?page=42